BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8106561)

  • 1. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
    Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F; Hui YN; Li YJ; Guo CM; Meng H
    Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the epidermal growth factor receptor during internalization in A-431 cells.
    Nesterov A; Lysan S; Vdovina I; Nikolsky N; Fujita DJ
    Arch Biochem Biophys; 1994 Sep; 313(2):351-9. PubMed ID: 8080283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.
    Matheson SL; McNamee JP; Jean-Claude BJ
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):11-20. PubMed ID: 12497201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
    Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
    Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
    Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
    Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.
    Zyzak LL; MacDonald LM; Batova A; Forand R; Creek KE; Pirisi L
    Cell Growth Differ; 1994 May; 5(5):537-47. PubMed ID: 8049160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
    Guyda HJ; Mathieu L; Lai W; Manchester D; Wang SL; Ogilvie S; Shiverick KT
    Mol Pharmacol; 1990 Feb; 37(2):137-43. PubMed ID: 2154666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient.
    Gross ME; Zorbas MA; Danels YJ; Garcia R; Gallick GE; Olive M; Brattain MG; Boman BM; Yeoman LC
    Cancer Res; 1991 Mar; 51(5):1452-9. PubMed ID: 1847663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
    Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion.
    Takahashi K; Suzuki K
    Exp Cell Res; 1996 Jul; 226(1):214-22. PubMed ID: 8660958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
    Faaland CA; Laskin JD; Thomas TJ
    Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
    Ahmad N; Gali H; Javed S; Agarwal R
    Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.